Life Sciences Tools and Services
Company Overview of Novella Clinical, Inc.
Novella Clinical, Inc., a clinical research organization, provides Phase I-IV clinical trial management services to clients in oncology, medical device, and biopharmaceutical industries. It offers program management, eCRF design and programming, EDC application hosting, study start-up and investigator recruitment, eClinical investigator and staff training, clinical monitoring, data management, biostatistics, medical writing, medical monitoring, pharmacovigilance, and regulatory consultation and management services in the areas of therapeutic concentration include cardiovascular disease, CNS, dermatology, endocrinology, oncology, urology, and infectious diseases, as well as general surgery an...
1700 Perimeter Park Drive
Morrisville, NC 27560
Founded in 1998
Key Executives for Novella Clinical, Inc.
Executive Vice President of Operations for Clinical Monitoring
Executive Vice President of Clinical Operations for Project Management & Training
Compensation as of Fiscal Year 2013.
Novella Clinical, Inc. Key Developments
Novella Clinical Announces Executive Appointments
Sep 11 13
Novella Clinical has named Deborah Turunjian as vice president of oncology clinical development, and Kathleen Zajd as vice president of global quality and compliance. The company has also promoted Jamie Gault to global head of regulatory affairs. Deborah Turunjian will lead further expansion of Novella's dedicated oncology division. Previously, Ms Turunjian served as executive leadership for Novella's business optimization and vendor management departments in addition to her oversight of western US business operations. Jamie Gault will oversee preparation of regulatory packages for agencies globally. Ms Zajd became an integral part of the Novella senior management team as a result of Novella's acquisition of Prologue Research International in 2010. Ms Zajd held leadership roles in clinical operations, regulatory and quality with experience spanning more than 25 years across both service organizations and sponsor (pharmaceutical and medical device) companies.
Novella Clinica Announces Executive Changes
Sep 3 13
Novella Clinica announced three senior executives have assumed new leadership roles within the organization. Deborah Turunjian has been named Vice President, Oncology Clinical Development and will lead further expansion of the company's oncology division. Previously, Ms. Turunjian served as executive leadership for the company's business optimization and vendor management departments in addition to her oversight of western U.S. business operations Prior to joining the company in 2010, Ms. Turunjian served as director of clinical operations for OSI Pharmaceuticals. Jamie Gault has been promoted to Global Head of Regulatory Affairs and will oversee preparation of regulatory packages for agencies globally. Having joined the company in 2012 in a senior quality assurance role. Finally, Kathleen Zajd has been named Vice President, Global Quality & Compliance. She became an integral part of the Novella senior management team as a result of Novella's acquisition of Prologue Research International in 2010.
Novella Clinical Announces Board Appointments
May 1 13
Novella Clinical announced two new hires to supplement business development efforts on the west coast. Joining as Directors of Client Business Development are Carole Gabos and Jeremie Braun. Carole Gabos is rejoining the company, having served in a business development role for the company in the early 2000s. Also joining is Jeremie Braun, who most recently served as a manager of business development for a cardiac safety services company.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 14, 2013